Objectives

After participating in this educational activity, attendees should be able to:
1|Evaluate evidence-based clinical, ethical, legal, social, philosophical, quality-of-life, safety, and economic factors to make informed decisions that support optimal patient care.


Presenter(s): 

Stephen Ryzewicz, MD
Committee Chair, moderator
Physician
Baystate Medical Center

Adam Pesaturo, PharmD
Pharmacy Coordinator
Pharmacist
Baystate Medical Center

Ashley McNamara, PharmD
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center

Danielle Ellis, PharmD
PGY2 Critical Care Pharmacy Resident
Pharmacist
Baystate Medical Center

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Adam Pesaturo, PharmDSpeakerNo relevant relationships with ineligible companies to discloseNo
Ashley McNamara, PharmDSpeakerNo relevant relationships with ineligible companies to discloseTerbutaline for extavasation management
Danielle Ellis, PharmDSpeakerNo relevant relationships with ineligible companies to discloseNo
Stephen Ryzewicz, MDModeratorNo relevant relationships with ineligible companies to discloseNo

 

Session date: 
11/11/2025 - 12:00pm to 1:30pm EST
Location: 
Baystate Medical Center / Zoom
759 Chestnut St
Springfield, MA 01199
United States
  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC Contact Hours
  • 1.50 BCIPE Risk Management
  • 1.50 IPCE Credit Hour(s)
Please login or register to take this course.